China NMPA Product Recall - Trauma Surgical Instrument Kit

Synthes GmbH, a Johnson & Johnson Medical company, initiated a voluntary global recall of specific trauma surgical instrument kits (Model 356.706, registration number: 国械备20150914). This action was reported to the National Medical Products Administration (NMPA) in China in March 2016 and publicly announced on April 13, 2016. The core issue identified was an incompatibility between the surgical instrument kits and their corresponding protective sleeves. This defect could cause interference during use, potentially leading to adverse events such as surgical delays, damage to surrounding tissues, bone injury, adverse tissue reactions, and abnormal bone healing. Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. served as the responsible entity for the recall within China under the NMPA's regulatory framework. Crucially, the company confirmed that none of the affected product batches were imported into or sold in China. Therefore, no direct corrective actions, such as product retrieval or replacement, were necessary within the Chinese market. The NMPA, in turn, requested provincial food and drug administrations to enhance their supervision of similar medical devices. This proactive recall highlights the company's commitment to patient safety worldwide, even in regions unaffected by product distribution.